Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 8, Issue 3 (2019)

Recombinant fusion 24.4 kDa protein based in house ELISA for serodiagnosis of paratuberculosis

Author(s):
Gokul Chand, Deepak Kumar, PP Goswami and NS Prasad
Abstract:
Paratuberculosis is a zoonotic chronic infectious enteric disease of ruminants caused by Mycobacterium avium subsp. paratuberculosis. ELISA based assay is ideal and sensitive for the screening of sera from infected animals. In this study, we use Map recombinant fusion 24.4 kDa protein developed by fusing the epitopic region of 300bp each from locus tag Map 0862 and locus tag Map 1637 to produce an in-house ELISA. The recombinant fusion 24.4 kDa was purified by single step chromatography using Ni-NTA Agarose. The recombinant fusion 24.4 kDa was reacted with anti- recombinant fusion 24.4 kDa antibodies as well as bovine and sheep sera infected with Map on western blot. A total of 106 animals samples were screened by commercial kit followed by Map recombinant fusion 24.4 kDa protein-based in-house ELISA. In-house ELISA using well-characterized sera (n=106) sample from sheep and bovine yielded a sensitivity of 85% and the specificity of 84.62%. The recombinant fusion 24.4 kDa used in the present study will prove useful as a diagnostic reagent in an in-house ELISA test.
Pages: 294-298  |  577 Views  65 Downloads


The Pharma Innovation Journal
How to cite this article:
Gokul Chand, Deepak Kumar, PP Goswami, NS Prasad. Recombinant fusion 24.4 kDa protein based in house ELISA for serodiagnosis of paratuberculosis. Pharma Innovation 2019;8(3):294-298.

Call for book chapter